New pill aims to curb impulsive behavior in opioid addiction

NCT ID NCT06628622

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times

Summary

This study tests an experimental medicine called BI 1356225 to see if it can help people with opioid use disorder control their impulses. About 60 adults aged 18 to 65 who are already taking buprenorphine for opioid addiction will be randomly assigned to receive either the study drug or a placebo for 8 days. Researchers will measure impulsivity using computer tasks and questionnaires, and monitor safety and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Collaborative Neuroscience Research, LLC, Los Alamitos

    Los Alamitos, California, 90720, United States

  • Hassman Research Institute-Marlton-66897

    Marlton, New Jersey, 08053, United States

  • University of California Los Angeles

    Los Angeles, California, 90095, United States

  • Virginia Commonwealth University

    Richmond, Virginia, 23298, United States

  • iResearch Atlanta

    Decatur, Georgia, 30030, United States

Conditions

Explore the condition pages connected to this study.